Damian A. Johnson
Impact in
- Oncology top 0.5%
- PARP inhibition in cancer therapy
- Cancer-related Molecular Pathways
- Reproductive Medicine top 1%
- Ovarian cancer diagnosis and treatment
Papers in
-
- Cell Adhesion Molecules Research 1
- Oncology 3
- PARP inhibition in cancer therapy 1
Damian A. Johnson
4 papers receiving 4.9k citations
Hit Papers
Peers
Comparison fields: 5 of 96
- Oncology 3.6k
- Reproductive Medicine 454
- Cancer Research 802
- Molecular Biology 3.5k
- Genetics 874
Countries citing papers authored by Damian A. Johnson
This map shows the geographic impact of Damian A. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Damian A. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Damian A. Johnson more than expected).
Fields of papers citing papers by Damian A. Johnson
This network shows the impact of papers produced by Damian A. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Damian A. Johnson. The network helps show where Damian A. Johnson may publish in the future.
Co-authors
The 25 scholars most cited alongside Damian A. Johnson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 75 | |
| 2 | 2010 | 50 | |
| 3 | 2007 | 71 | |
| 4 | Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy Hit paper breakdown → | 2005 | 4751 |
About Damian A. Johnson
Damian A. Johnson is a scholar working on Immunology and Allergy, Oncology, Cancer Research, Molecular Biology and Immunology, having authored 4 papers that have together received 4.9k indexed citations. Recurring topics across this work include Congenital heart defects research (1 paper), TGF-β signaling in diseases (1 paper), Galectins and Cancer Biology (1 paper), PARP inhibition in cancer therapy (1 paper), Glycosylation and Glycoproteins Research (1 paper), CRISPR and Genetic Engineering (1 paper), S100 Proteins and Annexins (1 paper) and Cell Adhesion Molecules Research (1 paper). The work is most often cited by research in Oncology (3.6k citations), Reproductive Medicine (454 citations), Cancer Research (802 citations), Molecular Biology (3.5k citations) and Genetics (874 citations). Damian A. Johnson has collaborated with scholars based in United Kingdom, Brazil and United States. Frequent co-authors include Christopher J. Lord, Alan Ashworth, Hannah Farmer, Manuela Santarosa, Nuala McCabe, Ian Hickson, Niall M.B. Martin, Graeme C.M. Smith, Charlotte Knights and Stephen P. Jackson. Their work appears in journals such as Nature, Oncogene, Cancer Research and Cancer Discovery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.